MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Illness perception in patients with Functional Movement Disorders: a case series

D. Campo-Caballero, L. Martínez, B. Martín, P. Rada, M. Kurtis, I. Pareés (San Sebastián, Spain)

Meeting: 2022 International Congress

Abstract Number: 597

Keywords: Psychogenic movement disorders(PMD): Clinical features, Psychogenic movement disorders(PMD): Treatment, Rehabilitation

Category: Functional Movement Disorders / Psychogenic Movement Disorders

Objective: To assess illness perception (IP) in a cohort of patients with Functional Movement Disorders(FMD)

Background: IP is the process by which individuals respond to a health threat by generating cognitive and emotional representations of the illness [1]. IP in patients with FMD has been scarcely investigated [2] even though changing patients’ IP has been shown to be crucial in the prognosis of several diseases. Patients with functional weakness and non-epileptic attacks report similar IP impact of symptoms compared to other neurological diseases [2-5].

Method: A prospective cohort study of FMD patients seen in a specialized FMD unit evaluating demographic, clinical data and IP as measured by the Brief Illness Perception Questionnaire (BIPQ). The scale consists of 9 items (1-8 rated by a 10-point likert scale from “better” to “worse”; Item 9 is an open response to “three most important causal factors”). BIPQ was obtained after a thorough diagnostic explanation and prior to treatment. BIPQ results are reported as median and IQR. Statistical analysis was performed using IBM-SPSS.

Results: Forty-one patients (53.7% females, mean age 49.3±13.6 years) were included. A combination of several FMD (n=15, 36.6%) and gait disturbance (n=14, 34.1%) were the most common phenotypes. Mean duration of symptoms was 64.2 months. Patients reported FMD to significantly affect their lives (9,7-10). FMD caused great concern (9,7-10) and had an emotional impact on patients’ lives (8,7-9). Patients reported to have low control over their symptoms (3,2-5) but believed that treatment might be helpful (8, 6-9). Most believed their illness would continue for a long time (7,5-9) and this perception did not correlate with disease duration (p=0.5). Accident/injury (n=18, 43.9%), stress/worry (n=14, 34.1%), emotional state (n=10; 24.4%), uncertainty (n=5; 12.2%) and overwork (n=5; 12.2%) were the most frequent causal factors reported by patients.

Conclusion: FMD have a significant physical and emotional impact on patients’ lives. Low personal control over symptoms and irreversibility are common beliefs in patients with FMD. Emotional and physical factors are perceived as the cause of the disorder rather than precipitating or aggravating it. Understanding FMD patients’ IP and beliefs is an essential part of the assessment and may provide helpful insight when planning multidisciplinary treatment.

References: 1- E. Broadbent, Keith J. Petrie, Jodie Main and John Weinman. The Brief Illness Perception Questionnaire. Journal of Psychosomatic Research 60 (2006) 631–637.
2- Stone J, Warlow C, Sharpe M. The symptom of functional weakness: a controlled study of 107 patients. Brain. 2010 May;133(Pt 5):1537-51. 
3- Sharpe M, Stone J, Hibberd C,Warlow C, Duncan R, Coleman R, et al. Neurology outpatients with symptoms unexplained by disease: illness beliefs and financial benefits predict 1-year outcome. Psychol Med 2009;1–10.
4- Whitehead K, Kandler R, Reuber M. Patients’ and neurologists’ perception of epilepsy and psychogenic nonepileptic seizures. Epilepsia 2013;54:708–17.
5- Stone J, Binzer M, Sharpe M. Illness beliefs and locus of control: a comparison of patients with pseudoseizures and epilepsy. J Psychosom Res 2004;57:541–7.

To cite this abstract in AMA style:

D. Campo-Caballero, L. Martínez, B. Martín, P. Rada, M. Kurtis, I. Pareés. Illness perception in patients with Functional Movement Disorders: a case series [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/illness-perception-in-patients-with-functional-movement-disorders-a-case-series/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/illness-perception-in-patients-with-functional-movement-disorders-a-case-series/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley